ASX 200 healthcare shares led the 11 market sectors last week with a 5.64% gain over the five trading days.

The S&P/ASX 200 Index (ASX: XJO) lifted 0.92% in the final trading week of FY26. 

The ASX 200 finished the week at 8,844.4 points.

This is the second time in three weeks that ASX 200 healthcare shares have been out in front. 

A sector rotation appears underway as value investors swoop on blue-chip favourites like CSL Ltd (ASX: CSL) and Pro Medicus Ltd (ASX: PME). 

The healthcare sector appears to have turned on 3 June when the S&P/ASX 200 Health Care Index (ASX: XHJ) hit a 9-year low.

That represented a 39% decline over 12 months. You can read comprehensive analysis of why the healthcare sector struggled in FY26 here.

Since then, healthcare shares have increased 20% in just one month compared to an 0.7% rise for the ASX 200 overall. 

In a new note, top broker UBS said ASX 200 healthcare shares and US biotech stocks both rose strongly in June, commenting:

There was limited company specific news to explain this recovery, suggesting it was due to broader market forces including sector rotation.

Healthcare was the worst performer among the 11 market sectors in FY26. You can read more about the market’s winners and losers in FY26 here. 

Now, let’s review some individual stock performances from last week.

Healthcare shares led the ASX sectors last week

The CSL share price rose 6.05% to $121.81 last week, and it’s up 32% since 3 June. 

Pro Medicus shares jumped 11% to $209.65 on Friday, and are up 31% since 3 June. 

Resmed CDI (ASX: RMD) shares ascended 5.39% to $30.50 last week, and are 18% higher since 3 June. 

Sonic Healthcare Ltd (ASX: SHL) shares rose 4.06% to $21.25 last week, and are up 13.1% over the month. 

The Ramsay Health Care Ltd (ASX: RHC) share price lifted 2.46% to $44.16 last week, and is up 21% since 3 June. 

The Cochlear Ltd (ASX: COH) share price increased 5.87% to $124.96 last week, and is up 31% since 3 June. 

Telix Pharmaceuticals Ltd (ASX: TLX) shares ripped 10.11% to $16.88 on Friday, and are up 38% over the month.

Respiratory imaging technology company 4DMedical Ltd (ASX: 4DX) rose 2.16% to $4.25 per share on Friday. 

4DMedical shares are up 12% since 3 June. 

The ASX 200 healthcare share was the best performer of the entire ASX 200 in FY26 after skyrocketing 1,786%. 

ASX 200 market sector snapshot

Here’s how the 11 market sectors stacked up last week, according to CommSec data.

Over the five trading days:

S&P/ASX 200 market sector	Change last week
Healthcare (ASX: XHJ)	5.64%
Information Technology (ASX: XIJ)	2.42%
Materials (ASX: XMJ)	2.08%
Financials (ASX: XFJ)	1.74%
Energy (ASX: XEJ)	0.74%
Communication (ASX: XTJ)	(0.91%)
Industrials (ASX: XNJ)	(1.04%)
Consumer Discretionary (ASX: XDJ)	(1.31%)
Consumer Staples (ASX: XSJ)	(1.68%)
A-REIT (ASX: XPJ)	(3.7%)
Utilities (ASX: XUJ)	(5.78%)

 

The post Healthcare shares lead the ASX 200 again as sector rotation gathers pace appeared first on The Motley Fool Australia.

More reading

• 3 ASX shares down at least 50% in FY26
• Top brokers name 3 ASX shares to buy next week
• Buy, hold, sell: Objective Corp, ResMed, and South32 shares
• How much do I need in superannuation to receive $5,500 per month in passive income?
• 10 of the best ASX shares to buy in FY 2027

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, ResMed, and Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended CSL, Cochlear, Pro Medicus, Sonic Healthcare, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

After a record-breaking year, S&P/ASX 200 Index (ASX: XJO) lithium stocks had a month to forget in June.

From market close on 29 May through to the closing bell on 30 June, the ASX 200 gained 0.5%.

Here’s how these ASX 200 lithium stocks performed over the month just past:

• Mineral Resources Ltd (ASX: MIN) shares tumbled 15.5% to close June at $62.07 apiece
• Liontown Resources Ltd (ASX: LTR) shares fell 30.2% to close June at $1.69 apiece
• PLS Group Ltd (ASX: PLS) – formerly Pilbara Minerals – shares dropped 22.3% to close June at $5.02 each
• IGO Ltd (ASX: IGO) shares tumbled 23.1% to close June at $7.37 apiece

What sent ASX 200 lithium stocks crashing lower?

The common headwind pressuring all the big Aussie lithium producers was a sharp pullback in spodumene (a lithium-bearing ore) prices. Spodumene prices fell around 12% in June, according to data from Trading Economics.

Though it’s important to note that the spodumene price remains up around 160% over past 12 months, which also still sees the ASX 200 lithium stocks racing ahead of the 1.5% one-year gains posted by the benchmark index.

Here’s what I mean (price data below through to 2 July):

• Mineral Resources shares are up 183.9% in 12 months
• Liontown shares are up 143.9% in 12 months
• PLS shares are up 273.0% in 12 months
• IGO shares are up 80.4% in 12 months

Which helps put the June retrace into some perspective!

What else moved the Aussie miners in June?

PLS shares closed down 4.7% on 19 June after the ASX 200 lithium stock reported that it had approved up to $175 million of spending ahead of the final investment decision (FID) at its P2000 Project, within its Pilgangoora hard-rock lithium operation.

The miner is studying the potential to increase Pilgangoora’s concentrate production capacity to around 2 million tonnes a year.

PLS CEO Dale Henders noted:

P2000 has the potential to represent the next major phase of growth at Pilgangoora and further strengthen PLS’ position as one of the world’s leading lithium producers. This pre-FID capital expenditure preserves optionality and maintains momentum along the critical path.

By progressing long-lead procurement, engineering and early works now, we are positioning PLS to respond to future lithium demand while retaining optionality for the timing of any final investment decision.

Mineral Resources was the only other ASX 200 lithium stock to release major news in June.

Mineral Resources shares closed down 2.5% on 25 June after the diversified miner announced that its Western Australia-based Lucky Bay Garnet Project would enter care and maintenance commencing on 1 July.

The company said it expects to book a non-cash impairment on the written down value of Lucky Bay of around $40 million for FY 2026.

The post Why did ASX 200 lithium stocks like PLS, Liontown and Mineral Resources shares get smashed in June? appeared first on The Motley Fool Australia.

More reading

• 9 ASX 200 shares with renewed buy ratings for FY27
• 5 best ASX 200 mining shares of FY26
• ASX shares vs. property in FY26: Which investment outperformed?
• 6 ASX 200 large-cap shares that rose 60% to 275% in FY26
• The ASX 200 sector that outperformed the benchmark 7 to 1 in FY26. Can it keep delivering?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares rose 2.77% and delivered total returns, including dividends, of 7% in FY26.  

The financials sector underperformed in FY26, which was in stark contrast to its outperformance in FY25.  

Financials were actually the best performer of the 11 market sectors in FY25, delivering a near-30% total return to investors.  

Things changed dramatically in FY26. 

The S&P/ASX 200 Financials Index (ASX: XFJ) fell 1.89%, but the 3.58% dividend yield lifted it into the green for a total return of 1.69%. 

Here are the top five ASX 200 financial shares for capital growth in FY26. 

1. Infratil Ltd (ASX: IFT)

Infratil is a New Zealand-based infrastructure investment company.

This ASX 200 financial share lifted 28.8% to finish the year at $12.61 apiece. 

One of the highlights of FY26 was Infratil’s data centre business, CDC Data Centres (CDC), signing Australia’s largest-ever data centre contract.  

CDC was already the largest data centre provider across Australia and New Zealand before the deal was done. 

The 30-year, 555MW agreement with a US customer highlighted the structural global theme of surging demand for artificial intelligence (AI) infrastructure. 

Infratil also delivered impressive earnings growth for FY26.

The company reported an 11% rise in proportionate operational EBITDAF to NZ$989 million. The company also raised its FY27 guidance by 21%.  

2. AMP Ltd (ASX: AMP)

The AMP share price rose 27.4% to close out the year at $1.61. 

AMP has been on a multi-year comeback journey following the Banking Royal Commission in 2018.

AMP was amongst the companies exposed for the worst conduct, prompting a multi-year restructure of the business. 

Brokers appear positive on the outlook for this ASX 200 financial share from here.  

As my colleague Samantha reports, AMP is focused on improving its operational leverage and looking at new capital relief strategies to boost returns. 

Out of 10 analysts rating AMP shares on the TradingView platform, eight have a strong buy or buy rating on AMP shares.

Nine analysts have provided a 12-month target price ranging from $1.68 to $1.94.

Thus, there is a uniform expectation of a further share price rise for AMP in FY27.

3. Challenger Ltd (ASX: CGF)

The Challenger share price rose 23.8% to finish at $10 on 30 June. 

This ASX 200 financial share went up on increased investor confidence that Challenger is gaining market share as Australia’s leading retirement income provider.

Arguably, the biggest catalyst for Challenger’s share price in FY26 was the 1H FY26 report.

Challenger reported record annuity sales of $3.8 billion, up 32% year over year.

The company also bumped up its fully-franked interim dividend by 7%, and launched a $150 million buyback.

This reinforced investor confidence in the earnings outlook ahead.

4. ANZ Group Holdings Ltd (ASX: ANZ)

The ANZ share price rose 21.2% to $35.35 on 30 June. 

New CEO Nuno Matos has been restructuring the business and integrating Suncorp Group Ltd (ASX: SUN)’s banking division post-acquisition. 

In 1Q FY26, ANZ achieved a quarterly cash profit of $1.94 billion, up 75% from the 2H FY25 quarterly average.

Management said the strong profit was driven by a 4% increase in operating income and a 21% cut in operating expenses.

The ASX 200 bank share rose 8.5% on the day of the report, and hit a record high of $41 the next day. 

This ASX 200 financial share is also attractive because it offers the highest trailing dividend yield of the big banks. 

5. Magellan Financial Group Ltd (ASX: MFG) 

The Magellan share price rose 13.2% to $9.69 on 30 June. 

The defining event in FY26 was Magellan’s proposed merger with the highly successful boutique investment bank, Barrenjoey Capital Partners.

Magellan and Barrenjoey completed the merger on 1 July. 

Former UBS bankers Matthew Grounds and Guy Fowler OAM founded Barrenjoey in 2020.

Magellan was a seed investor in Barrenjoey, and will seek shareholders’ approval to rebrand as Barrenjoey Group Limited at the October AGM.

Magellan received more than 90% approval from shareholders at the merger vote in April. 

This ASX 200 financial share has crumbled almost 80% over five years. The stock entered a downward spiral in 2021 after losing a major client. Its co-founder, Hamish Douglass, also resigned.

Assets under management have dropped from $113 billion in July 2021, when Magellan shares traded at $50 apiece, to $38 billion as of the last update in March. 

The post 5 best ASX 200 financial shares of FY26 appeared first on The Motley Fool Australia.

More reading

• Are AMP shares a good buy for passive income?
• 9 ASX 200 shares with renewed buy ratings for FY27
• Top ASX 200 share of each market sector in FY26
• This is the ASX bank stock I would buy today for franked dividend income
• How much passive income can I earn off a $100,000 portfolio?

Motley Fool contributor Bronwyn Allen has positions in Magellan Financial Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.